{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:20Z","timestamp":1790610740626,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1142043"],"award-info":[{"award-number":["1142043"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jinf.2020.09.032","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T19:34:16Z","timestamp":1601408056000},"page":"873-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review"],"prefix":"10.1016","volume":"81","author":[{"given":"Eva L.","family":"Sudbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinn","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jinf.2020.09.032_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"9514","key":"10.1016\/j.jinf.2020.09.032_bib0002","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"The Lancet"},{"key":"10.1016\/j.jinf.2020.09.032_bib0003","series-title":"Global public goods for health","year":"2003"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2020.09.032_bib0004","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/infdis\/jiu821","article-title":"Defining the needs for next generation assays for tuberculosis","volume":"211","author":"Denkinger","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.prrv.2010.09.008","article-title":"New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects","volume":"12","author":"Nicol","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"9","key":"10.1016\/j.jinf.2020.09.032_bib0006","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/INF.0000000000000796","article-title":"Diagnostic tests for childhood tuberculosis: past imperfect, present tense and future perfect?","volume":"34","author":"Tebruegge","year":"2015","journal-title":"Pediatr Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0007","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/S2214-109X(13)70036-6","article-title":"Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB\/RIF on respiratory specimens: a prospective study","volume":"1","author":"Zar","year":"2013","journal-title":"The Lancet Global Health"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0008","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S2213-2600(15)00095-8","article-title":"Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis","volume":"3","author":"Detjen","year":"2015","journal-title":"The Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respira J"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.2012.01002.x","article-title":"Purified protein derivatives of tuberculin - past, present and future","volume":"66","author":"Yang","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"10.1016\/j.jinf.2020.09.032_bib0011","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.2005.048033","article-title":"Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children","volume":"61","author":"Connell","year":"2006","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.jinf.2020.09.032_bib0012","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/INF.0000000000001195","article-title":"Interferon-gamma release assays should not replace tuberculin skin tests in screening programs for children","volume":"35","author":"Tebruegge","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"32","key":"10.1016\/j.jinf.2020.09.032_bib0013","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrmicro2236-c1","article-title":"Spectrum of latent tuberculosis: existing tests cannot resolve the underlying phenotypes","volume":"8","author":"Pai","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2020.09.032_bib0014","unstructured":"World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. 2013."},{"issue":"7","key":"10.1016\/j.jinf.2020.09.032_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120006","article-title":"Combined antigen-specific interferon-gamma and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection","volume":"10","author":"Chesov","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1378\/chest.13-1855","article-title":"A TB antigen-stimulated CXCR3 ligand assay for the diagnosis of active pulmonary TB","volume":"146","author":"Chung","year":"2014","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197825","article-title":"Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis","volume":"13","author":"Della Bella","year":"2018","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.09.004","article-title":"Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study","volume":"22","author":"Santin","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166501","article-title":"Potential role for Mycobacterium tuberculosis specific IL-2 and IFN-\u03b3 responses in discriminating between latent infection and active disease after long-term stimulation","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0021","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jinf.2014.10.019","article-title":"Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects","volume":"70","author":"Hur","year":"2015","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.jinf.2020.09.032_bib0022","doi-asserted-by":"crossref","first-page":"e43438","DOI":"10.1371\/journal.pone.0043438","article-title":"Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 Is a promising marker","volume":"7","author":"Borgstrom","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0023","doi-asserted-by":"crossref","first-page":"e59572","DOI":"10.1371\/journal.pone.0059572","article-title":"IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.09.032_bib0024","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tube.2017.04.005","article-title":"Chemokines additional to IFN-\u03b3 can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype","volume":"105","author":"Nonghanphithak","year":"2017","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0025","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1016\/j.ijid.2012.07.013","article-title":"Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis","volume":"16","author":"Hong","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.032_bib0026","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tube.2016.04.009","article-title":"Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects","volume":"99","author":"You","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2020.09.032_bib0027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","article-title":"Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting","volume":"114","author":"Clifford","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2020.09.032_bib0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","article-title":"Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection","volume":"111","author":"Petrone","year":"2018","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0029","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jinf.2018.04.011","article-title":"Combined IFN-gamma and TNF-alpha release assay for differentiating active tuberculosis from latent tuberculosis infection","volume":"77","author":"Kim","year":"2018","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.02758-14","article-title":"Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production","volume":"53","author":"Jeong","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0031","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tube.2007.03.004","article-title":"Interferon gamma\/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis","volume":"87","author":"Jamil","year":"2007","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0032","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-3083.2012.02776.x","article-title":"The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7","volume":"76","author":"Kim","year":"2012","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2020.09.032_bib0033","doi-asserted-by":"crossref","first-page":"e12365","DOI":"10.1371\/journal.pone.0012365","article-title":"Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort","volume":"5","author":"Sutherland","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.09.032_bib0034","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cyto.2016.10.013","article-title":"Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1\u03b2 and IL-18 in tuberculous lymphadenitis","volume":"90","author":"Kathamuthu","year":"2017","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"Suzukawa","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jinf.2020.09.032_bib0036","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tube.2014.07.002","article-title":"Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection","volume":"94","author":"Kim","year":"2014","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00759-17","article-title":"Potential immunological biomarkers for detection of Mycobacterium tuberculosis infection in a setting where M. tuberculosis is endemic, Ethiopia","volume":"86","author":"Teklu","year":"2018","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176495","article-title":"Diminished plasma levels of common gamma-chain cytokines in pulmonary tuberculosis and reversal following treatment","volume":"12","author":"Kumar","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0039","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-018-1572-x","article-title":"Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB","volume":"16","author":"Wang","year":"2018","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192664","article-title":"Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary non tuberculosis disease","volume":"13","author":"La Manna","year":"2018","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.jinf.2020.09.032_bib0041","doi-asserted-by":"crossref","first-page":"e79431","DOI":"10.1371\/journal.pone.0079431","article-title":"Mycobacterium tuberculosis-specific TNF-\u03b1 is a potential biomarker for the rapid diagnosis of active tuberculosis disease in Chinese population","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0042","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.tube.2015.08.003","article-title":"Immune parameters differentiating active from latent tuberculosis infection in humans","volume":"95","author":"Lee","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2020.09.032_bib0043","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tube.2017.07.013","article-title":"Multiplex analysis of plasma cytokines\/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants","volume":"107","author":"Yao","year":"2017","journal-title":"Tuberculosis"},{"issue":"8","key":"10.1016\/j.jinf.2020.09.032_bib0044","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","article-title":"Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls","volume":"16","author":"Biselli","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5588\/ijtld.16.0176","article-title":"Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis","volume":"21","author":"Kamakia","year":"2017","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"11","key":"10.1016\/j.jinf.2020.09.032_bib0046","doi-asserted-by":"crossref","first-page":"e79742","DOI":"10.1371\/journal.pone.0079742","article-title":"Combination of cytokine responses indicative of latent TB and active TB in Malawian adults","volume":"8","author":"Hur","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.09.032_bib0047","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tube.2015.05.015","article-title":"The effect of HIV coinfection, HAART and TB treatment on cytokine\/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals","volume":"96","author":"Kassa","year":"2016","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0048","article-title":"Cytokine and antibody based diagnostic algorithms for sputum culture-positive pulmonary tuberculosis","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0049","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tube.2012.12.002","article-title":"Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB","volume":"93","author":"Marin","year":"2013","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"Won","year":"2017","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0051","first-page":"19","article-title":"Evaluation of immunodiagnostic potential of ESAT-6 synthetic peptides mixture in Egyptian pulmonary tuberculosis patients","volume":"19","author":"Salman","year":"2012","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.jinf.2020.09.032_bib0052","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tube.2018.08.006","article-title":"Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection","volume":"112","author":"Balcells","year":"2018","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0053","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tube.2010.05.003","article-title":"Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis","volume":"90","author":"Marin","year":"2010","journal-title":"Tuberculosis"},{"issue":"9","key":"10.1016\/j.jinf.2020.09.032_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163848","article-title":"Cytokine patterns in tuberculosis infection; IL-1ra, IL-2 and IP-10 differentiate borderline QuantiFERON-TB samples from uninfected controls","volume":"11","author":"Wergeland","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2020.09.032_bib0056","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0057","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.5588\/ijtld.14.0945","article-title":"Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country","volume":"19","author":"Amanatidou","year":"2015","journal-title":"Int J Tuberculosis Lung Dis"},{"key":"10.1016\/j.jinf.2020.09.032_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01855","article-title":"A model based on the combination of IFN-\u03b3, IP-10, ferritin and 25-hydroxyvitamin D for discriminating latent from active tuberculosis in children","volume":"10","author":"Comella-Del-Barrio","year":"2019","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0059","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jinf.2013.08.005","article-title":"Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study","volume":"68","author":"Armand","year":"2014","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.jinf.2020.09.032_bib0060","doi-asserted-by":"crossref","first-page":"e46041","DOI":"10.1371\/journal.pone.0046041","article-title":"Potential role of M. tuberculosis specific IFN-gamma and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis","volume":"7","author":"Chiappini","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0061","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5588\/ijtld.16.0351","article-title":"Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis","volume":"21","author":"Nausch","year":"2017","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0062","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1371\/journal.pone.0003901","article-title":"Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?","volume":"3","author":"Whittaker","year":"2008","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0063","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/gene.2013.26","article-title":"Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India","volume":"14","author":"Dhanasekaran","year":"2013","journal-title":"Genes Immun"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0064","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/INF.0000000000001328","article-title":"Added value of IP-10 as a read-out of Mycobacterium tuberculosis: specific immunity in young children","volume":"35","author":"Jenum","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jinf.2020.09.032_bib0065","doi-asserted-by":"crossref","first-page":"e64226","DOI":"10.1371\/journal.pone.0064226","article-title":"Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting","volume":"8","author":"Chegou","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0066","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/00365548.2011.632644","article-title":"Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study","volume":"44","author":"Alsleben","year":"2012","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0067","first-page":"1548","article-title":"Cytokine responses to QuantiFERON peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis","volume":"14","author":"Lighter-Fisher","year":"2010","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0068","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/pr.2012.89","article-title":"TNF-alpha\/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study","volume":"72","author":"Gourgouillon","year":"2012","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0069","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis","volume":"192","author":"Tebruegge","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2020.09.032_bib0070","article-title":"Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting","volume":"16","author":"Sudbury","year":"2019","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0071","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jinf.2014.12.011","article-title":"Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker","volume":"70","author":"Mamishi","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.09.032_bib0072","unstructured":"World Health Organization. Global tuberculosis report 2019 2019 [Available from: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"10.1016\/j.jinf.2020.09.032_bib0073","unstructured":"The BCG World Atlas 2017 [cited 2020 15\/5\/2020]. 2nd:[Available from: www.bcgatlas.org."},{"issue":"5","key":"10.1016\/j.jinf.2020.09.032_bib0074","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"Walzl","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5411\/wji.v5.i1.16","article-title":"Role of cytokines and other factors involved in the Mycobacterium tuberculosis infection","volume":"5","author":"Romero-Adrian","year":"2015","journal-title":"World J Immunol"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0076","first-page":"731","article-title":"Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children","volume":"13","author":"Lighter","year":"2009","journal-title":"Int J Tuberculosis Lung Dis"},{"issue":"11","key":"10.1016\/j.jinf.2020.09.032_bib0077","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00018-003-3020-0","article-title":"Regulation of macrophage activation","volume":"60","author":"Ma","year":"2003","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0078","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1586\/ers.09.31","article-title":"Biomarkers of latent TB infection","volume":"3","author":"Ruhwald","year":"2009","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0079","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/156652407780598557","article-title":"Th2 cytokines in susceptibility to tuberculosis","volume":"7","author":"Rook","year":"2007","journal-title":"Curr Mol Med"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QCO.0b013e3283529af9","article-title":"Current understanding of the immune response to tuberculosis in children","volume":"25","author":"Basu Roy","year":"2012","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2020.09.032_bib0081","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3389\/fimmu.2018.02946","article-title":"The wonder years: what can primary school children teach us about immunity to Mycobacterium tuberculosis?","volume":"13","author":"Seddon","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0082","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-3083.1999.00492.x","article-title":"In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement","volume":"49","author":"Dlugovitzky","year":"1999","journal-title":"Scand J Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2020.09.032_bib0083","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0084","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0962-8479(94)90043-4","article-title":"Tuberculin reactivity after newborn BCG immunization in mono- and dizygotic twins","volume":"75","author":"Sepulveda","year":"1994","journal-title":"Tubercle Lung Dis"},{"issue":"12","key":"10.1016\/j.jinf.2020.09.032_bib0085","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1084\/jem.20090892","article-title":"Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis","volume":"206","author":"Cobat","year":"2009","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.jinf.2020.09.032_bib0086","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1128\/IAI.69.6.3989-3994.2001","article-title":"Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa","volume":"69","author":"Jepson","year":"2011","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.jinf.2020.09.032_bib0087","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1086\/375249","article-title":"Heritability analysis of cytokines as intermediate phenotypes of tuberculosis","volume":"187","author":"Stein","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0088","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/648611","article-title":"High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis disease","volume":"201","author":"Cobat","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2020.09.032_bib0089","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000088913","article-title":"Evidence for a major gene influence on tumor necrosis factor-alpha expression in tuberculosis: path and segregation analysis","volume":"60","author":"Stein","year":"2005","journal-title":"Hum Hered"},{"key":"10.1016\/j.jinf.2020.09.032_bib0090","series-title":"Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement","year":"2011"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0091","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","article-title":"Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA","volume":"38","author":"Elshal","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0092","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.b.20021","article-title":"Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers","volume":"61","author":"Khan","year":"2004","journal-title":"Cytometry Part B, Clin Cytometry"},{"issue":"1\u20132","key":"10.1016\/j.jinf.2020.09.032_bib0093","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2004.04.018","article-title":"Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1\/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants","volume":"29","author":"Prabhakar","year":"2004","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.jinf.2020.09.032_bib0094","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63A","author":"Leng","year":"2008","journal-title":"J Gerontol"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","article-title":"Multiplex bead array assays: performance evaluation and comaprison of sensitivity to ELISA","volume":"38","author":"Eshal","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0096","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1167\/iovs.05-0790","article-title":"Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNgamma profiles in uveitis","volume":"47","author":"Ooi","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0097","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CDLI.6.1.89-95.1999","article-title":"Variables that affect assays for plasma cytokines and soluble activation markers","volume":"6","author":"Aziz","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jinf.2020.09.032_bib0098","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1756-0500-6-120","article-title":"Comparison of whole blood and PBMC assays for T-cell functional analysis","volume":"6","author":"Deenadayalan","year":"2013","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.jinf.2020.09.032_bib0099","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138042","article-title":"Intracellular cytokine staining and flow cytometry: considerations for application in clinical trials of novel tuberculosis vaccines","volume":"10","author":"Smith","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2020.09.032_bib0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrmicro2236-c1","article-title":"Spectrum of latent tuberculosis existing tests cannot resolve the underlying phenotypes","volume":"8","author":"Pai","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.jinf.2020.09.032_bib0101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/resp.13272","article-title":"Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease","volume":"23","author":"Goletti","year":"2018","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0102","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ccm.2019.07.007","article-title":"Diagnostic tests for latent tuberculosis infection","volume":"40","author":"Haas","year":"2019","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jinf.2020.09.032_bib0103","unstructured":"World Health Organization. HIV\/AIDS Fact Sheet [updated 6 July 2020. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"issue":"4","key":"10.1016\/j.jinf.2020.09.032_bib0104","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01234-18","article-title":"Toward the development of a circulating free DNA-based in vitro diagnostic test for infectious diseases: a review of evidence for tuberculosis","volume":"57","author":"Fern\u00e1ndez-Carballo","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2020.09.032_bib0105","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1183\/09031936.00221514","article-title":"A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis","volume":"45","author":"Latorre","year":"2015","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jinf.2020.09.032_bib0106","doi-asserted-by":"crossref","first-page":"00115","DOI":"10.1183\/23120541.00115-2018","article-title":"Biomarkers for tuberculosis: the case for lipoarabinomannan","volume":"5","author":"Correia-Neves","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jinf.2020.09.032_bib0107","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3389\/fimmu.2018.02476","article-title":"A systematic review on novel Mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis","volume":"9","author":"Meier","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2020.09.032_bib0108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijid.2017.01.025","article-title":"A tuberculosis biomarker database: the key to novel TB diagnostics","volume":"56,","author":"Yerlikaya","year":"2017","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320306319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320306319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:30:04Z","timestamp":1759008604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320306319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0163445320306319"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.09.032","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}